|
1
|
Kothari R, Kreimer S, Nadel H, Seeley H, Hartman G, Meister KD. Use of Neoadjuvant Vandetanib in Aggressive Pediatric Medullary Thyroid Carcinoma. JCO Precis Oncol 2024; 8:e2300257. [PMID: 38207224 DOI: 10.1200/po.23.00257] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2023] [Revised: 10/16/2023] [Accepted: 11/03/2023] [Indexed: 01/13/2024] Open
Abstract
Novel use of vandetanib in a child with aggressive MTC with prolonged response to treatment.
Collapse
Affiliation(s)
- Ronik Kothari
- California University of Science and Medicine, Colton, CA
| | - Sara Kreimer
- Children's Thyroid Clinic at Stanford Medicine Children's Health, Palo Alto, CA
- Pediatric Oncology and Hematology, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA
| | - Helen Nadel
- Children's Thyroid Clinic at Stanford Medicine Children's Health, Palo Alto, CA
- Division of Pediatric Nuclear Medicine, Department of Radiology, Stanford University School of Medicine, Palo Alto, CA
| | - Hilary Seeley
- Children's Thyroid Clinic at Stanford Medicine Children's Health, Palo Alto, CA
- Division of Pediatric Endocrinology, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA
| | - Gary Hartman
- Children's Thyroid Clinic at Stanford Medicine Children's Health, Palo Alto, CA
- Division of Pediatric Surgery, Department of Surgery, Stanford University School of Medicine, Palo Alto, CA
| | - Kara D Meister
- Children's Thyroid Clinic at Stanford Medicine Children's Health, Palo Alto, CA
- Division of Pediatric Otolaryngology, Department of Otolaryngology-Head & Neck Surgery, Stanford University School of Medicine, Palo Alto, CA
| |
Collapse
|